Page 26 - Share Market Today

Emirates NBD infusion to lift RBL Bank's growth prospects: Motilal Oswal

RBL Bank's C/I ratio remains elevated at 70.7 per cent due to investments in retail, digital and risk infrastructure, and lower treasury income in Q2FY26.

Nuvama starts with 'Buy' on Yatharth Hospitals amid strong growth outlook

Despite healthy performance, Yatharth still operates below industry benchmarks in terms of ARPOB and occupancy, offering major upside potential.

Gujarat Pipavav, ESAB India among top stocks to buy today; check key levels

Kunal Kamble, senior technical research analyst at Bonanza, has recommended buying shares of Gujarat Pipavav, Ashapura Minechem, and ESAB India today

Stock Market Highlights: Sensex slips 435 pts, Nifty ends at 25,840; SMIDs outperform; IT leads fall

Sensex Today | Stock Market LIVE Updates, December 9, 2025: In the broader markets, the Nifty MidCap index was up 0.32 per cent, and the Nifty SmallCap index was up 1.14 per cent

Nephrocare Health IPO opens Dec 10: Should you bid? Here's what experts say

Nephrocare Health IPO comprises a fresh issue of 7.7 million, amounting to ₹353.4 crore and an offer for sale (OFS) of 11.3 million equity shares amounting to ₹517.64 crore

Park Medi World IPO: Analysts split on prospects; should you apply?

The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025

Aequs IPO listing on December 10: Here's what latest GMP indicates

Ahead of its listing, the unlisted shares of Aequs were trading at around ₹152 per share in the grey market, indicating a premium of ₹28 or 22.6 per cent

Delhivery rises 4% on rolling out 'Delhivery International' for Indian MSME

Around 1 PM, Delhivery shares were trading at day's high level, up 3.96 per cent at ₹412.50. In comparison, BSE Sensex was trading 0.36 per cent lower at 84,795.25 levels.

Why did SpiceJet share rise 8% in overall weak market today? Find here

SpiceJet shares rose after the airline announced the induction of two Boeing 737 aircraft into its fleet, boosting its operational capacity on key domestic and international routes.

D-St rout extends as Sensex falls 700 pts intraday; here's what happened

In the broader market, the Nifty Midcap 100 and Nifty Smallcap 100 indices fell 1.5 per cent, each. The small-cap index has fallen 3.3 per cent since Monday

Defence, aerospace to drive Bharat Forge; CV outlook unclear: Motilal Oswal

At the core of the bullish narrative is BHFC's swelling defence order book, now at nearly ₹114,000 crore and executable over the next three to four years.

Stock Market Highlights: Sensex tumbles 609 pts; Nifty ends below 26k; Realty cracks 3%; VIX up 8%

Sensex Today | Stock Market Highlights, December 8, 2025: In the broader markets, Nifty Midcap 100 index closed 1.83 per cent lower, while Nifty SmallCap 100 index settled 2.6 per cent lower

Investing in Nephrocare Health IPO? Check 5 key risks before you decide

Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares

Stock Market close: Sensex jumps 447 pts, Nifty at 26,186 as investors cheer RBI rate cut

Sensex Today | Stock Market close, Dec 5, 2025: In the broader markets, the Nifty MidCap index gained 0.49 per cent, and the Nifty SmallCap index dropped 0.57 per cent

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA Sec

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside

Largecaps to outperform in 2026 as SMID valuations look stretched: BofA

Bank of America (BofA) Securities said it continues to prefer largecaps over small and midcaps (SMIDs) in CY26 as valuations remain elevated and risks are skewed to the downside